CXCL9 and rheumatoid arthritis: Previous studies have shown that Th1 cells in the synovial fluid of patients with RA highly express CXCR3 and its ligands and that CXCR3 binds to the ligands CXCL9/MIG and CXCL-10/IP-10 to exert chemotactic effects.